Related Experiment Videos
Use of a human tumor cloning system to screen retinoids for antineoplastic activity
Abstract:
Retinoid analogs are being actively evaluated as antitumor agents in man. A human tumor cloning system was used to assess the antineoplastic activity of all-trans-retinoic acid, all-trans-retinol and 13-cis-retinoic acid. The effect of retinoids on the formation of tumor colony forming units (T-CFU) was surveyed for 67 different human tumors. These analogs showed minor activity in a variety of neoplasms. The decrease in T-CFU varied between histologic tumor types and between tumor of the same type. No significant difference between retinoid analogs was noted.
Insights
Retinoid analogs like all-trans-retinoic acid showed minor antitumor activity against human tumors. The effectiveness varied across tumor types, with no significant differences observed among the tested retinoid analogs.
Area of Science:
- Oncology
- Pharmacology
Background:
- Retinoid analogs are investigated for their potential as anticancer drugs.
- Understanding their efficacy in human neoplasms is crucial for therapeutic development.
Purpose of the Study:
- To evaluate the antineoplastic activity of specific retinoid analogs against a diverse range of human tumors.
- To assess the impact of retinoids on tumor colony-forming units (T-CFU).
Main Methods:
- A human tumor cloning system was employed.
- The study surveyed the effects of all-trans-retinoic acid, all-trans-retinol, and 13-cis-retinoic acid.
- The impact on T-CFU formation was assessed across 67 human tumor types.
Main Results:
- Retinoid analogs demonstrated minor anticancer activity across various neoplasms.
- The reduction in T-CFU varied significantly based on histologic tumor type and even among tumors of the same type.
- No substantial differences in efficacy were found between the different retinoid analogs tested.
Conclusions:
- The tested retinoid analogs exhibit limited efficacy as antitumor agents in human tumors.
- Further research may be needed to identify specific retinoid analogs or combinations with enhanced antineoplastic properties.